Pathway Overdispersion
Expression Details
geneCluster.115 | 39.58 | 15.01 | |
geneCluster.130 | 34.4 | 13.79 | |
geneCluster.126 | 33.02 | 13.15 | |
geneCluster.138 | 33.39 | 11.33 | |
geneCluster.135 | 28.6 | 8.97 | |
GO:0008009 chemokine activity (MF) | 31 | 8.66 | |
geneCluster.116 | 24.41 | 7.49 | |
geneCluster.28 | 25.59 | 7.49 | |
GO:0043209 myelin sheath (CC) | 25.7 | 7.48 | |
geneCluster.95 | 35.99 | 7.25 | |
geneCluster.140 | 25.38 | 7.23 | |
geneCluster.136 | 24.65 | 6.74 | |
geneCluster.123 | 17.07 | 6.68 | |
geneCluster.132 | 13.79 | 6.45 | |
geneCluster.143 | 20.24 | 6.05 | |
geneCluster.9 | 25.08 | 5.69 | |
GO:0030593 neutrophil chemotaxis (BP) | 21.22 | 5.63 | |
geneCluster.118 | 16.02 | 5.48 | |
geneCluster.134 | 18.2 | 5.43 | |
geneCluster.26 | 17.74 | 5.4 | |
GO:0006935 chemotaxis (BP) | 28.32 | 5.34 | |
geneCluster.127 | 18.71 | 5.18 | |
geneCluster.119 | 17.95 | 5.15 | |
GO:0006955 immune response (BP) | 29.34 | 4.81 | |
GO:0042552 myelination (BP) | 19.22 | 4.73 | |
GO:0006911 phagocytosis, engulfment (BP) | 14.17 | 4.58 | |
geneCluster.129 | 21.52 | 4.42 | |
GO:0032760 positive regulation of tumor necrosis factor production (BP) | 17.87 | 4.41 | |
geneCluster.31 | 16.1 | 4.29 | |
GO:0002237 response to molecule of bacterial origin (BP) | 12.17 | 4.19 | |
GO:0005125 cytokine activity (MF) | 24.4 | 4.18 | |
geneCluster.13 | 14.75 | 4 | |
geneCluster.17 | 14.77 | 3.95 | |
GO:0006954 inflammatory response (BP) | 26.91 | 3.93 | |
geneCluster.125 | 17.95 | 3.86 | |
geneCluster.101 | 16.59 | 3.85 | |
GO:0050729 positive regulation of inflammatory response (BP) | 14.42 | 3.73 | |
GO:0045672 positive regulation of osteoclast differentiation (BP) | 11.83 | 3.65 | |
GO:0070098 chemokine-mediated signaling pathway (BP) | 10.67 | 3.64 | |
geneCluster.51 | 16.45 | 3.63 | |
GO:0042742 defense response to bacterium (BP) | 15.52 | 3.6 | |
GO:0006958 complement activation, classical pathway (BP) | 12.5 | 3.59 | |
geneCluster.120 | 17.87 | 3.54 | |
geneCluster.124 | 15.04 | 3.49 | |
GO:0006898 receptor-mediated endocytosis (BP) | 15.45 | 3.41 | |
geneCluster.141 | 20.56 | 3.4 | |
GO:0019221 cytokine-mediated signaling pathway (BP) | 15.98 | 3.37 | |
geneCluster.89 | 17.62 | 3.37 | |
GO:0016831 carboxy-lyase activity (MF) | 10.03 | 3.3 | |
geneCluster.133 | 11.24 | 3.27 | |
geneCluster.34 | 13.15 | 3.27 | |
geneCluster.38 | 17.03 | 3.16 | |
GO:0050766 positive regulation of phagocytosis (BP) | 11.22 | 3.16 | |
geneCluster.6 | 11.26 | 3.13 | |
geneCluster.36 | 13.1 | 3.13 | |
GO:0050840 extracellular matrix binding (MF) | 10.35 | 3.07 | |
GO:0050715 positive regulation of cytokine secretion (BP) | 10.77 | 3.05 | |
GO:0008360 regulation of cell shape (BP) | 16.63 | 3.05 | |
GO:0050830 defense response to Gram-positive bacterium (BP) | 12.01 | 3.04 | |
geneCluster.10 | 15.45 | 3 | |
GO:0006952 defense response (BP) | 10.22 | 2.93 | |
GO:0016525 negative regulation of angiogenesis (BP) | 12.66 | 2.88 | |
GO:0042157 lipoprotein metabolic process (BP) | 7.59 | 2.86 | |
GO:0050776 regulation of immune response (BP) | 8.69 | 2.81 | |
GO:0050806 positive regulation of synaptic transmission (BP) | 8.07 | 2.8 | |
geneCluster.86 | 10.99 | 2.79 | |
GO:0019835 cytolysis (BP) | 7.23 | 2.76 | |
geneCluster.102 | 13.77 | 2.74 | |
GO:0043292 contractile fiber (CC) | 7.66 | 2.7 | |
GO:0045087 innate immune response (BP) | 17.12 | 2.69 | |
GO:0005902 microvillus (CC) | 10.09 | 2.67 | |
GO:0030500 regulation of bone mineralization (BP) | 7.25 | 2.65 | |
GO:0009611 response to wounding (BP) | 9.1 | 2.64 | |
GO:0005771 multivesicular body (CC) | 7.49 | 2.62 | |
geneCluster.137 | 11 | 2.61 | |
GO:0030169 low-density lipoprotein particle binding (MF) | 7.47 | 2.61 | |
GO:0001664 G-protein coupled receptor binding (MF) | 8.52 | 2.6 | |
GO:0032755 positive regulation of interleukin-6 production (BP) | 9.61 | 2.57 | |
GO:0035094 response to nicotine (BP) | 6.68 | 2.56 | |
GO:0016126 sterol biosynthetic process (BP) | 8.73 | 2.56 | |
GO:0048712 negative regulation of astrocyte differentiation (BP) | 7.25 | 2.56 | |
GO:0005540 hyaluronic acid binding (MF) | 7.87 | 2.55 | |
GO:0008514 organic anion transmembrane transporter activity (MF) | 6.42 | 2.55 | |
GO:0007010 cytoskeleton organization (BP) | 11.91 | 2.54 | |
GO:0043220 Schmidt-Lanterman incisure (CC) | 6.37 | 2.54 | |
GO:0005179 hormone activity (MF) | 9.79 | 2.53 | |
geneCluster.16 | 14.51 | 2.53 | |
GO:0000302 response to reactive oxygen species (BP) | 7.09 | 2.52 | |
geneCluster.106 | 12.78 | 2.51 | |
GO:0007210 serotonin receptor signaling pathway (BP) | 6.21 | 2.5 | |
geneCluster.60 | 14.92 | 2.49 | |
GO:0019838 growth factor binding (MF) | 8.98 | 2.48 | |
GO:0006629 lipid metabolic process (BP) | 19.5 | 2.47 | |
geneCluster.66 | 13.11 | 2.47 | |
GO:0044130 negative regulation of growth of symbiont in host (BP) | 6.03 | 2.45 | |
GO:2001240 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (BP) | 7.79 | 2.45 | |
GO:0016209 antioxidant activity (MF) | 6.59 | 2.44 | |
GO:0005520 insulin-like growth factor binding (MF) | 7.51 | 2.44 | |
GO:0045776 negative regulation of blood pressure (BP) | 7.35 | 2.44 | |
geneCluster.92 | 10.39 | 2.42 | |
GO:0051044 positive regulation of membrane protein ectodomain proteolysis (BP) | 5.89 | 2.41 |